Results 21 to 30 of about 13,841 (201)

Varicella Zoster vaccination in hemodialysis patients: The state of the art

open access: yesHuman Vaccines & Immunotherapeutics, 2023
Varicella Zoster Virus (VZV) infection is a common childhood exanthematous disease, which in adults and immunocompromised people may result in severe neurologic complications.
Laura Gobbi   +4 more
doaj   +1 more source

Varicella paediatric hospitalisations in Belgium : a 1-year national survey [PDF]

open access: yes, 2016
Background: Varicella universal vaccination (UV) has been implemented in many countries for several years. Nevertheless, varicella UV remains debated in Europe and few data are available on the real burden of infection.
Belgian Group for Varicella, the   +4 more
core   +2 more sources

Safety of live attenuated varicella-zoster vaccine in patients with underlying illnesses compared with healthy adults: a prospective cohort study

open access: yesBMC Infectious Diseases, 2019
Background In Japan, freeze-dried live attenuated varicella-zoster vaccine is available for adults aged ≥50 years to prevent herpes zoster. However, limited evidence has been accumulated regarding vaccine safety for patients with underlying illnesses ...
Satoko Ohfuji   +7 more
doaj   +1 more source

High prevalence of antibodies to human herpesvirus 8 in relatives of patients with classic Kaposi's sarcoma from Sardinia [PDF]

open access: yes, 1998
A survey for antibodies to a recombinant small viral capsid antigen (sVCA) of human herpesvirus type 8 (HHV‐8) was conducted in Sardinia, one of the world's highest incidence areas for classic Kaposi's sarcoma (KS). Prevalence of antibodies to HHV‐8 sVCA
Angeloni, Antonio   +11 more
core   +1 more source

Varicella vaccine strain infection in a non-immunocompromised patient. A case report and review of literature

open access: yesHuman Vaccines & Immunotherapeutics, 2021
Varicella live attenuated vaccine led to a significant reduction in morbidity and mortality from varicella zoster disease. Vaccine adverse effects are mostly mild. Immunosuppression is the main risk factor for severe varicella.
Rana Swed-Tobia   +5 more
doaj   +1 more source

Vaccines for prophylaxis of viral infections in patients with hematological malignancies. [PDF]

open access: yes, 2011
Viral infections cause significant morbidity and mortality in patients with hematological malignancies. It remains uncertain whether viral vaccinations in these patients are supported by good evidence.
Chan, GC   +4 more
core   +1 more source

Vaccination recommendations for adult patients with autoimmune inflammatory rheumatic diseases [PDF]

open access: yes, 2015
BACKGROUND: The number of individuals with autoimmune inflammatory rheumatic diseases (AIIRDs) treated with immunosuppressive drugs is increasing steadily.
Bühler, S.   +7 more
core   +4 more sources

Twelve Children with Varicella Vaccine Meningitis: Neuropathogenesis of Reactivated Live Attenuated Varicella Vaccine Virus

open access: yesViruses, 2020
Varicella vaccine is a live attenuated varicella-zoster virus (VZV). Like its parental strain called VZV pOka, the vaccine virus vOka retains some neurotropic properties.
Ethan H. Heusel, Charles Grose
doaj   +1 more source

Cost-effectiveness of herpes zoster vaccines in the U.S.: A systematic review

open access: yesPreventive Medicine Reports, 2022
The purpose of this study was to conduct a systematic review to evaluate the cost-effectiveness evidence of herpes zoster vaccines in the U.S. A systematic literature review was undertaken for U.S.
Neil R. Meredith, Edward P. Armstrong
doaj   +1 more source

Characterization of potential biomarkers of reactogenicity of licensed antiviral vaccines: randomized controlled clinical trials conducted by the BIOVACSAFE consortium [PDF]

open access: yes, 2019
Funding text The authors are grateful for the vital contributions of the participating study volunteers, clinicians, nurses, and laboratory technicians at the Surrey study site.
Bodinham, C.   +16 more
core   +1 more source

Home - About - Disclaimer - Privacy